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Introduction and the  
Importance of Diet
After several years in the practice of  health care and watching an increase in 
immune-complex disorders, inflam-
matory disorders and degenerative 
diseases, I believe it is time for the 
health care community to initiate 
Cross-Talk. One recent study reports 
a healthy lifestyle combining not 
smoking, a healthy weight, a healthful 
diet including moderate alcohol con-
sumption, and daily exercise reduced 
ischemic strokes by approximately 
half  in both men and women.1 The 
transfer of  this critical information 
to all health care providers is impor-
tant to the long-term health of  all. 
This represents the essence of  the 
Cross-Talk. 
Most specialties and sub-specialties 
are publishing discoveries within 
their own journals without commu-
nicating those findings to other dis-
ciplines in spite of  the fact that the 
results may have direct impact on 
the management of  a different body 
system. As an example, how many 
health care practitioners who treat 
herpes zoster have read:
"Herpes zoster. The treatment and 
prevention of  neuralgia with adenos-
ine monophosphate. 2
Thirty-two adults were enrolled in 
a randomized, placebo-controlled 
double-blind trial of  intramuscular 
injections of  gel-sustained adenosine 
monophosphate (AMP) given three 
times a week for up to four weeks 
for acute herpes zoster. Adenosine 
mono phosphate moderately re-
duced the pain soon after the start of  
treatment, decreased desquamation 
time, and promoted faster healing of  
the skin than placebo treatment. Ad-
enosine monophosphate treatment 
reduced virus shedding and cleared 
the virus faster than in placebo-treated 
subjects. At the end of  the initial 
four-week treatment period, 88% 
of  AMP-treated patients were pain 
free, as opposed to only 43% in the 
placebo group. After four weeks, all 
patients who had not recovered from 
pain started receiving AMP treat-
ment without breaking the code. All 
these patients recovered from pain 
within three weeks after initiation of  
treatment. No recurrence of  pain or 
lesions was experienced from three 
to 18 months after the end of  treat-
ment. Adenosine monophosphate, a 
natural cellular metabolite, showed 
no side effects or toxicity during and 
after the treatment." 
The eye provides an excellent 
model to illustrate the impact of  one 
discipline on another.  Cardiologists 
are well aware of  the potential of  
some nutritional supplements in the 
management of  vascular disorders. 
Vascular alteration to the eye results 
in a number of  disorders includ-
ing glaucoma and macular degen-
eration. Why then would an eye care 
professional not want to realize the 
ongoing thought process in cardiol-
ogy.  Dermatology realizes that Co-
enzyme Q10 (CoQ10) levels reflect 
the likelihood for the progression 
of  malignant melanoma, one of  the 
more dreaded ocular conditions. 
Of  particular interest is the be-
havior of  our society in the creation 
of  nutritional deficiencies.  Poverty, 
drug side effects, drug abuse, al-
coholism, gastric bypass (bariatric 
surgery), fad diets, and just igno-
rance may be opening a door to the 
genesis of  an entirely new set of  
nutritionally-based diseases and dis-
orders. A question that we all must 
ask in relation to the work-up of  any 
ocular disease patient must include 
nutritionally-related issues. 3  The 
decreased survival of  AREDS par-
ticipants with Age-Related Macular 
Degeneration (AMD) and cataracts 
suggests that these conditions may 
reflect systemic rather than only lo-
cal processes.4  Vitamin A deficiency 
at the least may become an issue as-
sociated with fat mal-absorption as-
sociated with bariatric surgery5 which 
will then impact directly on the gen-
esis of  dysfunctional tear syndrome. 
Vitamin B12 and folate deficiency is 
also related to mal-absorption and 
is well known to create ocular side 
effects with a strong relationship to 
hyperhomocysteinemia which repre-
sents a major cardiovascular threat. 6-9 
In spite of  a purportedly healthy diet 
in the US 10%-14% of  Americans 
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have a vitamin C deficiency, 10 and up 
to 15% of  adults over 60 years of  age 
have laboratory evidence of  B12 de-
ficiency.6 Treatment of  the majority 
patients with these readily obtainable 
nutrients involves basic diet good 
sense or supplementation as well as 
exercise and general modification 
of  behavior including cessation of  
smoking and minimizing the use of  
alcohol. It continues to amaze that 
patients believe in the magic bullet. 
A recent study points out that despite 
eating a diet rich in omega-3 fatty 
acids, Alaskan Eskimo patients are 
developing subclinical atherosclero-
sis at an early age, likely due in large 
part to heavy smoking.11 The thrust 
of  the message in this discussion is 
that synergism is key rather than an 
isolated monotherapy approach in 
the management of  most chronic, 
neurodegenerative, and inflamma-
tory disorders.  Modulation (balance) 
is the critical watchword in the ap-
proach to the management of  health 
in most individuals while minimizing 
risk. Radical behavior or unbalanced 
therapy can and will create far more 
harm than good.  Exercise potenti-
ates effects and combinant therapies 
represent the theme of  recent “eu-
rekas.”  Regular exercise and consum-
ing long-chain n-3 fatty acids (FAs) 
from fish or fish oil can independent-
ly improve cardiovascular and meta-
bolic health, but combining these 
lifestyle modifications may be more 
effective than either treatment alone. 
(Am J Clin Nutr 2007;85:1267)  There 
is no magic pill, but rather a mental 
set and lifestyle that set the tone for 
maximizing health. While we should 
expect everyone to modulate their 
behavior to maximize their health 
it just will not happen so we must 
arm ourselves to become “personal 
health advisors” to our patients.  A 
recent review study corroborates this 
stating that healthy lifestyle habits in-
clude not smoking, maintenance of  
optimal BMI, moderate alcohol con-
sumption, and daily exercise.  In men 
and women, maintenance of  healthy 
lifestyle habits is associated with an 
80% reduction in the risk for stroke.1
Another critical issue regarding 
supplementation is that the health 
care provider is often unaware of  the 
patient’s use of  non-pharmaceutical 
products.  Vitamin E and Gingko bi-
loba may not be reported in patients 
using blood thinners.  Prothrombin 
times (PT) will definitely be affected 
by the utilization of  many supple-
ments leading to the possibility of  
increased bleedability. In a survey con-
ducted in 1999, about 49% of  adult 
Americans were estimated to have 
used herbal products during the previ-
ous year. It has been documented that 
as many as 31% of  the patients who 
use herbal supplements do so in con-
junction with prescribed drugs and 
about 70% of  these patients do not 
regularly report the use of  these prod-
ucts to their health care providers. 12-13
Another enlightening report speaks 
to the use of  complementary medi-
cine use in cancer survivors. It is 
reported that prayer and spiritual 
practice were the most prevalent 
methods, reported by 61.4% of  
survivors. This was followed by re-
laxation (44.3%), faith and spiritual 
healing (42.4%), nutritional supple-
ments and vitamins (40.1%), medi-
tation (15%), religious counseling 
(11.3%), massage (11.2%), and sup-
port groups (9.7%). Hypnosis was 
least likely to be used (0.4%), and 
biofeedback therapy (1.0%) and 
acupuncture/acupressure (1.2%) were 
used only slightly more often.14
One critical issue to address is the 
validity of  claims that evolve from 
scientific studies. This discussion is 
intended to be scientifically-based 
to provide the reader with an under-
standing of  the potential of  behav-
ioral issues as they relate to the gen-
esis of  ocular and systemic disorders. 
With that in mind be cognizant of  
the fact that numerous claims by a 
plethora of  studies have yet to be sub-
stantiated. The difficulty in develop-
ing incontrovertible evidence stems 
from the complexity of  human trials. 
Extrapolation of  some of  the con-
cepts of  basic research to clinical ap-
plication is possible, but guarded op-
timism is the watchword until clinical 
trials support results. Any analysis of  
published reports must be tempered 
by the structure of  the study. Peter 
McDonnell in a recent editorial in 
Ophthalmology Times February 15, 
2006, discusses “Are you skeptical of  
the latest peer-reviewed results?”  Dr. 
McDonnell cites an article by Ioan-
nidis regarding the fact that Ioanni-
dis reviewed 49 “important” research 
articles published in top medical 
journals between 1990 and 2003 and 
subsequently cited 1000 times.  Over 
33% of  these articles were found to 
be wrong.” 15-17  Critical review of  
new ideas prior to translation of  the 
information to the general health 
care delivery team is critical in the 
evolution of  any educational model. 
Increased fraud in publication of  tri-
als also seems to be on the increase 
with printed retractions occurring 
far after the potential impact of  the 
results18-19 as well as an excess of  ap-
parently significant clinical findings.20 
One Canadian study provided an 
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interesting commentary on industry-
sponsored research on prostaglandin 
medications. They found that indus-
try-funded studies were significantly 
more likely (19/27 studies = 70%) 
to have abstract conclusions that did 
not match the actual reported main 
outcomes of  the study than were 
non-industry-funded investigations 
(2/12 = 17%, P = .002). Conclusions 
of  the abstracts in industry-funded 
studies were supportive of  the com-
pany’s drug 89% of  the time.21
With the caveat of  guarded op-
timism the investigation of  the lit-
erature regarding cross-talk may be 
initiated.
Diet That Supports Anti-
Inflammation, Neuropro-
tection and Overall Ocular 
Health
The eyes are truly the window to both 
the soul and functioning of  the body. 
All aspects of  health are ultimately 
reflected in the health of  the eye but 
the direct cause-effect relationship is 
evasive because of  the cumulative ef-
fect of  one’s actions.  Diet and diets 
both affect the health of  the eyes. 
An abusive diet, drug interactions, 
and toxicities create health issues 
within the cardiovascular, endocrine 
and neurological systems that reflect 
in ocular function.  Likewise radical 
diets and bariatric surgery rob the 
body of  essential nutrients to pro-
mote proper function.  This discus-
sion will but touch the high points 
of  diet, behavioral modification and 
supplementation but will speak to 
the importance of  a coordinated ef-
fort in preventing and managing sys-
temic and thus ocular disorders.  
Excessive weight and obesity in 
concert with an inappropriate diet 
loom as a constant threat to both sys-
temic and ocular health. 22-23 Morbid-
ity and mortality are both affected by 
diet with a prudent approach being to 
maintain your weight at a reasonable 
level while concurrently consuming 
health-sustaining nutrients. There 
are studies linking obesity to macular 
degeneration.24 In one report over-
all and abdominal obesity increased 
the risk for progression to advanced 
AMD, and more physical activity 
tended to decrease risk. 25-26  Ironically 
there is also increased risk should 
the patient be too thin implying the 
influence of  malnourishment.27 An-
other recent report suggests that in 
Latinos cardiovascular risk factors 
may play a role in advanced AMD. 28 
This should be of  no surprise since 
Richer’s original work demonstrated 
that cardiovascular risk factors in-
cluding serum Fe levels contributed 
to the progression of  AMD. 29-30   The 
other risk factors often associated 
with heart disease such as smoking 
and altered blood composition are 
also modifiable in our patient base. 
31-35 Reports also attest to the fact 
that obesity is actually related to a de-
crease in macular pigment levels that 
may be attributable to an inherent 
competition with adipose tissue. 36-38 
Serum levels of  lutein and zeaxan-
thin are the true measures of  efficacy 
of  the protective effects of  diet and 
both levels are measured lower with 
obesity and diabetes.36  All of  these 
studies still do not absolutely indi-
cate the need for diet control from 
a scientific standpoint, but studies 
point to the necessity for cessation 
of  smoking in minimizing the risk 
for AMD. 39
From the standpoint of  cataract 
development there has been much 
discussion regarding diet. While very 
specific, some studies show a link of  
metabolic syndrome with the genesis 
of  cataracts.40-41  It appears that there 
is a link between oxidative stress and 
cataract formation with smoking 
again being implicated.42 In general it 
also appears that obesity is a positive 
marker for the increased likelihood 
of  cataract formation but a  bit un-
predictable based on the type of  cat-
aract.43-45  With a higher Body Mass 
Index (BMI), abdominal obesity, and 
diabetes, patients develop a higher 
incidence of  cortical and posterior 
sub-capsular cataracts.46-47
The link to diabetes and obesity 
(most specifically the metabolic syn-
drome) is incontrovertible.48-51 Meta-
bolic syndrome denotes a common 
cluster of  naturally connected risk 
factors including obesity, elevated 
blood pressure, insulin resistance, 
dyslipidemia, proinflammatory state 
and prothrombotic state.  This sce-
nario (the metabolic syndrome) has 
the potential to lead to multiple reti-
nal vascular flow issues within the 
eye. 52 The link to diabetic retinopa-
thy is more circumspect but studies 
have linked retinal microvasculopathy 
to metabolic syndrome.49, 53  Inhibition 
of  inflammatory mediators is likewise 
implicated in minimizing diabetes 
risks 54 and can be achieved by dietary 
modification.  A diet designed to ad-
dress the metabolic syndrome may 
be the direction to go to minimize 
the risk of  diabetic retinopathy, but 
clinical trials must corroborate this 
conclusion. Additionally one must 
address other situations that may in-
crease oxidative stress and decrease 
oxygenated blood supply to the eye 
such as smoking and sleep apnea. 
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There also exists an association of  
weight issues to glaucoma.  There 
is certainly a suggestion that there 
is an association of  insulin resis-
tance and the metabolic syndrome 
to increased intraocular pressure.55 
Body Mass Index appears to have 
an association with elevated intra-
ocular pressure.56-59  Certainly initial 
reaction to this fact among clini-
cians would be to point to neck size 
and positive pressure as a related 
factor with sleep apnea falling into 
the picture.60-61  The relationship of  
cerebrospinal fluid pressure eleva-
tion, Idiopathic Intracranial Hyper-
tension, serum cortisol, and sleep 
apnea also create an interesting 
scenario for elevated intraocular 
pressure.62  While further analysis 
from a scientific standpoint is criti-
cal, it does appear, quite logically, 
that obesity has a link to glaucoma 
if  from no other standpoint than 
physical restriction of  flow.  
Cordain contends that our West-
ern diet has evolved in a disparate 
manner from our basic biological 
needs.63  The contention is that we 
still have cave-man genes (geno-
type) requiring the Paleolithic diet 
that are not being properly nour-
ished by our current diet. This ab-
errant diet then creates an oxidative 
stress that impacts on the inflam-
matory reaction as well as the im-
mune system.  Oxidative stress in 
glaucoma leads to alterations in 
Retinal Ganglion Cells that precipi-
tate damage. Similar results could 
be expected in other ocular disor-
ders. Without proper conversion 
of  these radicals the stress creates 
a poison to the system.64  Phyto-
chemicals such as green or black 
tea 65-67, coffee 68, dark chocolate 
69, and red wine 70-71 contain poly-
phenolic compounds that act as 
free radical scavengers.72  A recent 
paper looking at a subset of  black 
women attests to the fact that con-
suming three or more servings of  
fruit each day was associated with 
a 79% decrease in glaucoma risk 
compared with eating less than one 
serving per day.73  Likewise as one 
would expect, in another study re-
garding African American Women, 
a higher intake of  soft drinks and 
fruit drinks was associated with 
an increased incidence of  Type 2 
Diabetes.74  Balance (MODULA-
TION) is the watchword in any 
issue of  diet, supplementation and 
behavioral modification.  
Additionally a recent study of-
fers the following recommenda-
tions for an anti-inflammatory diet 
to improve the overall health and 
most specifically the cardiovascular 
system which has strong implica-
tions in all ocular disorders with 
carry over to  neurodegenerative 
diseases.  C-reactive protein levels 
are a very good indicator of  the 
presence of  systemic inflamma-
tion and have been shown to be 
elevated in many ocular disorders. 
Any disease with elevated C-reac-
tive proteins will potentially benefit 
from an anti-inflammatory diet.
“This anti-inflammatory diet 
should be considered for the pri-
mary and secondary prevention of  
coronary artery disease and diabe-
tes.” 75
n The glycemic index of  a food 
is defined as the incremental 
increase in the area under the 
postprandial glucose curve after 
ingestion of  50 g of  a specific 
amount of  food versus that 
associated with 50 g of  oral glu-
cose. Ideal carbohydrates with 
a low glycemic index include 
green leafy vegetables such as 
broccoli and spinach and fruits 
such as grapefruits and cherries. 
Select high-fiber carbohydrates 
with low glycemic index, includ-
ing vegetables, fruits, whole 
grains, legumes, and nuts. 
n Excess intake of  processed 
carbohydrates leads to a  
vicious cycle of  transient spikes 
in blood glucose levels, increased 
insulin production, and reac-
tive hypoglycemia. Avoid highly 
processed foods and beverages, 
particularly those containing 
sugar, high-fructose corn syrup, 
white flour, or trans fats. 
n Berries, dark chocolate, red 
wine, tea, and pomegranates re-
duce postprandial oxidant stress 
and inflammation.  Cacao beans 
contain a subclass of  flavonoids 
which have been reported to 
augment eNOS and thereby 
NO.  This improves endotheli-
um-dependent vaso-relaxation.76 
One study showed that one 
square of  dark chocolate was 
6.3 g and represented only 30 
kcal per day but previous studies 
have shown that 100 g of  dark 
chocolate lowers BP by 12/8 
mm Hg but with the risk of  
increased caloric intake.77
n	 Coffee contains antioxidants 
and can improve insulin sensi-
tivity. Consumption of  black tea 
reduces platelet activation and 
plasma levels of  C-reactive pro-
tein. However, previous research 
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has not demonstrated a consistent 
reduction in the risk for stroke 
associated with coffee or tea 
consumption. One study suggests 
that higher levels of  coffee and 
tea consumption can reduce the 
risk for cerebral infarction among 
male smokers but not risk rates of  
intracranial hemorrhage. 78
n	 When paired with a high-glyce-
mic-index meal, cinnamon slows 
gastric emptying and reduces 
postprandial glucose excursion.  
n	 Nuts also slow gastric emptying 
and can reduce the impact of  
high-glycemic-index carbohy-
drates by as much as half. Nuts 
also reduce postprandial oxidative 
protein damage, and consumption 
of  nuts at least 5 times weekly can 
reduced the risks for coronary 
artery disease and diabetes by 
20% to 50%. Eat approximately 
1 handful of  nuts daily (using 
a closed fist), consumed with 
vegetables, grains, berries, or other 
fruits. 
n	 Vinegar can reduce postprandial 
glycemia and promotes satiety. 
Eat salad daily, consisting of  leafy 
greens with dressing of  vinegar 
and virgin olive oil. 
n	 Lean protein reduces postprandial 
glucose excursion and improves 
satiety. Such protein includes egg 
whites, game meat, skinless poul-
try breast meat, and whey protein 
or other nonfat dairy protein. At 
all 3 meals, consume lean protein. 
n	 Drinking 0.5 to 1 alcoholic drink 
per day for women and 1 to 2 
alcoholic drinks per day for men 
can reduce cardiovascular risk, and 
1 to 2 drinks before a meal can 
reduce postprandial glucose and 
insulin levels. However, higher 
levels of  drinking can impair glu-
cose metabolism.  
n	 Exercise acutely lowers glucose 
and triglyceride levels in a dose-
dependent fashion.Perform 
physical activity for at least 30 
minutes or more daily, of  at least 
moderate intensity.
n	 Maintain normal weight and 
avoid overweight or obesity. Waist 
circumference should be less than 
one half  of  height in inches. 
It has been demonstrated that a 
low glycemic index diet is benefi-
cial for both weight loss and lipid 
profiles.79 Additionally women in 
the highest quintile of  consump-
tion of  a high-fat, low-fiber diet 
had an increase in the relative risk 
of  developing colon cancer of  1.46 
compared with those in the lowest 
quintile. However, consumption of  
a high-fiber and healthy protein diet 
was associated with a trend toward 
reduced rates of  colon cancer. Diet 
did not significantly affect the risk 
for rectal cancer.80
In a perfect world where we all ate 
the Paleolithic diet, exercised, main-
tained the proper weight and did not 
consume any substances with poten-
tial toxicity, supplementation would 
be totally unnecessary.  However, the 
world is less than perfect and even 
the most well-meaning are faced with 
less than optimal lifestyles, therefore 
there must be some attention paid to 
reminders and supplementation. It 
is also critical that with any of  these 
considerations, potential toxicities 
and interactions must be addressed.  
Part two of  this series will start to 
address the reported benefits of  
specific nutrients and supplements.
Dr. Alexander receives no reimbursement 
from any nutritional supply company.  
He serves as an advisor on the Biosyntrx 
board for no remuneration. He is the  
Director of  Clinical Education for 
Optovue, Inc, a digital imaging company, 
which produces the RTVue.
ChArACteristiCs OF the  
MetABOLiC sYnDrOMe
1. Abdominal obesity
2. Atherogenic dyslipidemia
3. Elevated Blood Pressure
4. High insulin levels-over 10
 a. Raises fats into cells
 b. Promotes fat storage
 c. Stimulates arterial smooth muscle  
cells
 d. Promotes production of bad types         
of eicosanoid (EC) -intracellular 
hormones
 e. Series one ECs are good and may be 
inhibited by too much flaxseed
 f. Series two ECs are bad-glucagon is 
a strong inhibitor of EC 2 pathway
5. Promotes retention of fluids by kidneys
 glucagon is the anti-insulin and 
is increased by high proteins low 
carbohydrates
6. High levels of inflammatory mediators 
as measured by C-Reactive Protein 
levels
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